A new US/Canadian cross-border partnership will expand access for patients who turn to pharmacists for medication therapy management services. Minneapolis, USA-based Medication Management Systems, has partnered with Medication Management Canada, to adapt its groundbreaking electronic therapeutic record, the Assurance System, for the Canadian health care market.
"Our common goal is to improve patient care by rapidly expanding medication therapy management services delivered by pharmacists across Canada," said Linda Strand, co-founder and vice president of professional services for MMS. She added: "MMS' Assurance System provides pharmacists a clinical decision support system and electronic therapeutic record to promote common practice standards, document therapeutic outcomes, and improve patient care - the infrastructure pharmacists have needed."
"Pharmacy practice in Canada is becoming more integrated with the patient's care team, requiring a significant change from the current practice to include new methods and tools," explained Sunny Loo, executive director of MMC, adding: "the benefits of the Assurance System, as an integral part of this evolving pharmaceutical care role, became apparent and our partnership with MMS puts us in the ideal position to support Canadian pharmacists in meeting this challenge."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze